Vestor Capital, LLC Abb Vie Inc. Transaction History

Vestor Capital, LLC

$1.24 Billion
Q2 2024

A detailed history of Vestor Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vestor Capital, LLC holds 13,488 shares of ABBV stock, worth $2.61 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

13,488

Previous 13,858 2.67%

Holding current value

$2.61 Million

Previous $2.52 Million 8.36%

% of portfolio

0.19%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $57,272 - $66,881	-370 Reduced 2.67%	13,488 $2.31 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $4,474 - $5,098	-28 Reduced 0.2%	13,858 $2.52 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $58,480 - $65,862	425 Added 3.16%	13,886 $2.15 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $94,180 - $109,028	-705 Reduced 4.98%	13,461 $2.01 Million
Q2 2023 Aug 21, 2023	SELL	$132.51 - $164.9 $14 Million - $17.4 Million	-105,473 Reduced 88.16%	14,166 $1.91 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $11.8 Million - $14.7 Million	89,117 Added 291.98%	119,639 $34.3 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $84.1 Million - $96.8 Million	-581,261 Reduced 95.01%	30,522 $4.86 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $83.9 Million - $96.6 Million	580,104 Added 1831.19%	611,783 $30 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $139,969 - $167,860	-1,012 Reduced 3.1%	31,679 $5.12 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $9.52 Million - $10.9 Million	-70,968 Reduced 68.46%	32,691 $4.39 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $5.59 Million - $7.1 Million	40,595 Added 64.37%	103,659 $15.9 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $6.62 Million - $8.22 Million	50,183 Added 389.59%	63,064 $10.2 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $44,690 - $56,546	-416 Reduced 3.13%	12,881 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $113,209 - $128,509	1,064 Added 8.7%	13,297 $1.43 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $3,219 - $4,346	40 Added 0.33%	12,233 $1.31 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $30,669 - $35,996	-357 Reduced 2.84%	12,193 $1.07 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $408,994 - $620,086	-6,341 Reduced 33.57%	12,550 $956,000
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $104,516 - $130,772	1,449 Added 8.31%	18,891 $1.67 Million
Q3 2019 Nov 20, 2019	BUY	$62.98 - $75.72 $84,078 - $101,086	1,335 Added 8.29%	17,442 $1.32 Million
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $11,497 - $14,696	-175 Reduced 1.07%	16,107 $1.17 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $126,432 - $148,804	-1,639 Reduced 9.15%	16,282 $1.31 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $18,494 - $24,765	-201 Reduced 1.11%	17,921 $1.7 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $890,853 - $976,894	9,947 Added 121.68%	18,122 $1.75 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $571,023 - $729,373	8,175	8,175 $726,000

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.

Account

Vestor Capital, LLC Abb Vie Inc. Transaction History